What is Brooke Shadel's NPI number?

Brooke Shadel's National Provider Identifier (NPI) is 1134327018, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Brooke Shadel's specialty?

Brooke Shadel is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Brooke Shadel located?

Brooke Shadel's practice location on file with NPPES is 615 S New Ballas Rd, Saint Louis, MO 63141-8221.

What is Brooke Shadel's phone number?

The practice phone number listed in the NPPES registry for Brooke Shadel is (314) 251-6000.

Does Brooke Shadel accept Medicare?

Brooke Shadel is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Brooke Shadel's NPI active?

Yes — Brooke Shadel's NPI (1134327018) is active in the NPPES registry as of the last update on 2007-07-08.

IndividualActiveAccepts Medicare

Brooke Shadel, MD, PHD, MPH

NPI 1134327018 · Dermatology Physician · Saint Louis, MO

Brooke Shadel, MD, PHD, MPH is a Dermatology Physician provider in Saint Louis, MO (NPI 1134327018).

Provider details

NPI number: 1134327018
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: MD, PHD, MPH
Sex: Female
Sole proprietor: No
License: 2007018113 (MO)

Practice location

615 S New Ballas Rd

Saint Louis, MO 63141-8221

Phone: (314) 251-6000

Street-level locationGet directions

More MO providers

Mailing address

5700 Milentz Ave

Saint Louis, MO 63109-3528

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense 2007018113 (MO)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(81/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
19 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
3,650 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	1,098	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	886	$87
Destruction of Precancer Skin Growth, 1 Growth17000	431	$48
Biopsy of Related Skin Growth, First Growth11102	339	$84
Destruction of Skin Growth, 1-14 Growths17110	282	$105
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 24 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	164	89
Triamcinolone Acetonide	110	88
Fluocinonide	77	64
Nystatin	76	31
Fluorouracil	72	70
Metronidazole	58	40
Betamethasone/Propylene Glycbrand: Betamethasone Diprop Augmented	47	35
Mupirocin	46

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$454 across 19 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2007-07-03
Last updated: 2007-07-08

Frequently asked questions

What is Brooke Shadel's NPI number?: Brooke Shadel's National Provider Identifier (NPI) is 1134327018, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Brooke Shadel's specialty?: Brooke Shadel is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Brooke Shadel located?: Brooke Shadel's practice location on file with NPPES is 615 S New Ballas Rd, Saint Louis, MO 63141-8221.
What is Brooke Shadel's phone number?: The practice phone number listed in the NPPES registry for Brooke Shadel is (314) 251-6000.
Does Brooke Shadel accept Medicare?: Brooke Shadel is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Brooke Shadel's NPI active?: Yes — Brooke Shadel's NPI (1134327018) is active in the NPPES registry as of the last update on 2007-07-08.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	1,098	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	886	$87
Destruction of Precancer Skin Growth, 1 Growth17000	431	$48
Biopsy of Related Skin Growth, First Growth11102	339	$84
Destruction of Skin Growth, 1-14 Growths17110	282	$105
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 24 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	164	89
Triamcinolone Acetonide	110	88
Fluocinonide	77	64
Nystatin	76	31
Fluorouracil	72	70
Metronidazole	58	40
Betamethasone/Propylene Glycbrand: Betamethasone Diprop Augmented	47	35
Mupirocin	46

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$454 across 19 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments